欧洲药典适用性证书数据库
(Certificates of Suitability to the monographs of European Pharmacopoeia, EDQM)
专论编号 物质名称 证书持有人 持有人ORG-ID和LOC-ID 证书编号 发布日期 证书状态 到期续期 证书结束日期 证书类型 上一程序的结束日期 历史数据
程序类型|结论|日期
2288 Citalopram hydrobromide, CTP Process HETERO DRUGS LIMITED Hyderabad IN 100008415;100014434 CEP 2012-120 - Rev 05 2025/08/01 Valid Chemical 2025/08/01 Minor revision|CEP granted|01/08/2025;
Minor revision|CEP granted|11/09/2024;
Minor revision|CEP granted|17/11/2021
2760 Brimonidine tartrate SIEGFRIED GRAFTON, INC. Grafton US 100042515;100070251 CEP 2015-265 - Rev 01 2025/08/01 Valid Chemical 2025/08/01 Notification|CEP granted|01/08/2025;
Notification|Accepted - CEP remains valid|02/05/2024;
Notification|Accepted - CEP remains valid|04/05/2023;
Renewal|CEP granted|24/01/2023;
Notification|CEP granted|27/08/2021
2675 Irinotecan hydrochloride trihydrate LAURUS LABS LIMITED Hyderabad IN 100011702;100032608 CEP 2019-292 - Rev 03 2025/08/01 Valid 19/10/2026 Chemical 2025/08/01 Minor revision|CEP granted|01/08/2025;
Minor revision|Rejected|23/05/2025;
Minor revision|Accepted - CEP remains valid|25/11/2024;
Minor revision|CEP granted|11/12/2023;
Minor revision|CEP granted|26/01/2023
2258 Olanzapine SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai IN 100032307;100078783 CEP 2012-050 - Rev 04 2025/07/31 Valid Chemical 2025/07/31 Notification|CEP granted|31/07/2025;
Major revision|CEP granted|14/05/2025;
Minor revision|CEP granted|21/02/2023
1295 Calcifediol monohydrate FORMOSA LABORATORIES, INC. Taoyuan TW 100011879;100018688 CEP 2019-163 - Rev 03 2025/07/31 Valid 28/10/2026 Chemical 2025/07/31 Minor revision|CEP granted|31/07/2025;
Minor revision|CEP granted|27/08/2024;
Notification|Rejected|08/07/2024;
Administrative procedure|CEP granted|16/11/2021
2593 Docetaxel FUJIAN SOUTH PHARMACEUTICAL CO., LTD. Sanming CN 100012371;100021536 CEP 2016-204 - Rev 05 2025/07/31 Valid Chemical 2025/07/31 Minor revision|CEP granted|31/07/2025;
Renewal|CEP granted|20/12/2023;
Minor revision|CEP granted|03/10/2022;
Minor revision|CEP granted|16/03/2021
1781 Fludarabine phosphate TAPI NL B.V. Amsterdam NL 100003852;100094134 CEP 2005-257 - Rev 06 2025/07/31 Valid Chemical 2025/07/31 Minor revision|CEP granted|31/07/2025;
Minor revision|CEP granted|09/04/2024;
Notification|Accepted - CEP remains valid|09/09/2022;
Notification|CEP granted|10/11/2021;
Notification|Accepted - CEP remains valid|25/03/2021
2631 Rosuvastatin calcium CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram IN 100038839;100060978 CEP 2022-009 - Rev 02 2025/07/31 Valid 01/06/2028 Chemical 2025/07/31 Minor revision|CEP granted|31/07/2025;
Minor revision|CEP granted|14/05/2024;
Notification|Rejected|22/03/2024;
New application|CEP granted|01/06/2023
2338 Mirtazapine MEGA FINE PHARMA PRIVATE LIMITED Mumbai IN 100011550;100021133 CEP 2024-116 - Rev 00 2025/07/31 Valid 31/07/2030 Chemical 2025/07/31 New application|CEP granted|31/07/2025
1076 Bumetanide MEDILUX LABORATORIES PRIVATE LIMITED Pithampur IN 100023732;100032901 CEP 2024-248 - Rev 00 2025/07/31 Valid 31/07/2030 Chemical 2025/07/31 New application|CEP granted|31/07/2025
3139 Brivaracetam ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City CN 100012174;100018701 CEP 2025-089 - Rev 00 2025/07/31 Valid 31/07/2030 Chemical 2025/07/31 New application|CEP granted|31/07/2025
2541 Quetiapine Fumarate, ID 3871 TAPI NL B.V. Amsterdam NL 100003852;100094134 CEP 2020-234 - Rev 03 2025/07/31 Valid Chemical 2025/07/31 Renewal|CEP granted|31/07/2025;
Minor revision|CEP granted|19/12/2023;
Notification|CEP granted|22/02/2022;
New application|CEP granted|13/11/2020
1524 Gliclazide BAL PHARMA LIMITED Bengaluru IN 100016398;100041736 CEP 2001-273 - Rev 08 2025/07/30 Valid Chemical 2025/07/30 Administrative procedure|CEP granted|30/07/2025;
Notification|CEP granted|19/06/2025;
Notification|CEP granted|21/03/2025;
Notification|CEP granted|23/10/2023;
Minor revision|CEP granted|17/04/2023
2015 Ebastine BAL PHARMA LIMITED Bengaluru IN 100016398;100041736 CEP 2013-051 - Rev 04 2025/07/30 Valid Chemical 2025/07/30 Administrative procedure|CEP granted|30/07/2025;
Notification|CEP granted|19/06/2025;
Notification|CEP granted|22/04/2024;
Minor revision|CEP granted|28/11/2022
333 Heparin sodium HELM PORTUGAL UNIPESSOAL LDA. Carnaxide PT 100004498;100075893 CEP 2002-012 - Rev 08 2025/07/30 Valid Chemical 2025/07/30 Notification|CEP granted|30/07/2025;
Major revision|CEP granted|27/11/2024;
Monograph revision|Accepted - CEP remains valid|19/06/2024;
Major revision|CEP granted|09/10/2020
1524 Gliclazide, AP BAL PHARMA LIMITED Bengaluru IN 100016398;100041736 CEP 2013-039 - Rev 04 2025/07/30 Valid Chemical 2025/07/30 Administrative procedure|CEP granted|30/07/2025;
Notification|CEP granted|23/06/2025;
Administrative procedure|CEP granted|03/03/2025;
Minor revision|CEP granted|13/02/2025;
Renewal|CEP granted|27/08/2020
267 Caffeine HEBEI GUANGXIANG PHARMACEUTICAL CO. LTD. Cangzhou CN 100048186;100079867 CEP 2024-083 - Rev 01 2025/07/30 Valid 17/06/2030 Chemical 2025/07/30 Administrative procedure|CEP granted|30/07/2025;
New application|CEP granted|17/06/2025
1093 Cyclopentolate hydrochloride ESTEVE QUIMICA S.A. Barcelona ES 100002266;100056508 CEP 2016-078 - Rev 01 2025/07/30 Valid Chemical 2025/07/30 Minor revision|CEP granted|30/07/2025;
Minor revision|Accepted - CEP remains valid|11/01/2024;
Renewal|CEP granted|19/10/2022;
Transfer of holdership|CEP granted|16/03/2022;
Administrative procedure|CEP granted|22/07/2020
845 Mebendazole, Form-C, micronised and non-micronised MSN LIFE SCIENCES PRIVATE LIMITED Medak IN 100018316;100027671 CEP 2018-242 - Rev 02 2025/07/30 Valid Chemical 2025/07/30 Renewal|CEP granted|30/07/2025;
Minor revision|CEP granted|19/08/2022
1425 Fosfomycin trometamol NORTHEAST PHARMACEUTICAL GROUP CO. LTD Shenyang CN 100021339;100054155 CEP 2023-201 - Rev 01 2025/07/30 Valid 20/05/2030 Chemical 2025/07/30 Notification|CEP granted|30/07/2025;
New application|CEP granted|20/05/2025

数据库说明:

当前数据更新日期:2025年12月22日。
©2006-2025 DrugFuture->Certificates of Suitability to the monographs of European Pharmacopoeia, EDQM